Facilitating the interpretation of rare pathogenic ... · Facilitating the interpretation of rare...
Transcript of Facilitating the interpretation of rare pathogenic ... · Facilitating the interpretation of rare...
Facilitating the interpretation of rare pathogenic variation in a clinical
setting with DECIPHER. Jawahar Swaminathan, Ph.D.
04/12/2014 https://decipher.sanger.ac.uk 1
• Aiding the interpretation of genomic variants since 2004
• Primary Objective Facilitate identification and interpretation of pathogenic genetic variation in rare disorders
• Mission making genetic and phenotypic data discoverable to enable improved interpretation of variation that cannot be unambiguously interpreted in isolation
04/12/2014 https://decipher.sanger.ac.uk 2
DECIPHER at-a-glance
https://decipher.sanger.ac.uk 04/12/2014 3
• 1300+ registered users
• 250+ Projects
• 43 countries
• 40K+ patient records (52k variants) • ~15K shared publicly (anonymised). • 10K+ under managed access
Deposition • Patient Info • Variant (CNV/SNV) • Phenotypes (HPO) • Bulk or single upload
04/12/2014 https://decipher.sanger.ac.uk 4
Registered users
only
Search
04/12/2014 https://decipher.sanger.ac.uk 5
Searching publicly shared data does not require login. Logged in user search results take into account user access
Coming soon: Advanced Search e.g “seizures and 20q13.3”
Analysis: Search Results Karyotype view of Chr 20 for patients with phenotype “Seizures”
04/12/2014 https://decipher.sanger.ac.uk 6
Search term:
seizures
Choose karyotype in results
Analysis: Prioritization and Matchmaking
04/12/2014 https://decipher.sanger.ac.uk 7
Matched Patients
Analysis: information • Variant Properties • Gene Resources
04/12/2014 https://decipher.sanger.ac.uk 8
Analysis: visualization
04/12/2014 https://decipher.sanger.ac.uk 9
My variant
Other Variants in DECIPHER
Overlapping CNVs
ClinVar
LSDB
Genoverse HTML5 interactive, customisable browser
DECIPHER Collaborative Framework
04/12/2014 https://decipher.sanger.ac.uk 10
Peer-to-Peer Between DECIPHER registered users on patients on mutual interest using “Contacts” option.
External User to Peer DECIPHER mediates contact and collaboration requests from external to registered users
Bulk anonymous data for research Available to bona fide researchers under Data Access and Display agreements.
Programmatic Access Development of API as part of the GA4GH and Matchmaker Exchange initiatives
In Progress
Collaboration
DECIPHER members can contact each other directly. DECIPHER also forwards over 50 external contact requests every year.
04/12/2014 https://decipher.sanger.ac.uk 11
Since 2011, 600+ publications have used shared DECIPHER data.
Data from any rare disease study that collects phenotype-linked variation data can be analyzed and shared from within DECIPHER.
Eur J Med GenetMarch 2013
DECIPHERData from Belgium,
Netherlands
DECIPHER Data Model
• Private – visible to depositing project only
• Managed: Visibility restricted to users of named consortia
• Public – anonymised data available to all after patient consent
Managed sharing allows data (research or clinical) to be shared between collaborators and named consortia without being available to all.
Private
Public
Clinical
Managed
04/12/2014 https://decipher.sanger.ac.uk 13
Research MDA
consent
Explicit consent, or publication
• Patient can be public or private
• Variants in a patient can be • Not shared • Shared with one or more
consortia (anonymised) • Shared publicly (fully
anonymised)
• Limited sharing reaches more people than unshared.
• Public sharing reaches a vastly greater audience.
Sharing
04/12/2014 https://decipher.sanger.ac.uk 14
Sharing Customisable sharing of variant within a patient
Variant visibility depends on patient consent status and user access level. A variant can only be seen by public if the patient has given appropriate consent.
04/12/2014 https://decipher.sanger.ac.uk 15
Private
Managed
Public
DECIPHER’s 10 year experience - thoughts
• Building depositor trust, engender a sharing ecosystem • Meeting varied user needs (clinical, lab, research) • Catering to both research and clinical communities • Information depth vs. usability • Easy availability of data (search, API, bulk download)
04/12/2014 https://decipher.sanger.ac.uk 16
Acknowledgements
04/12/2014 https://decipher.sanger.ac.uk
• Patients and families for permission to include their data in DECIPHER
• Members of the DECIPHER consortium
Ben Hutton
17
Daniel Perrett